PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
22-Jan-2026 Cencora Elects Ellen Cooper to Its Board of Directors Businesswire
22-Jan-2026 Point of Care Ultrasound Market Set to Reach USD 8.4 Billion by 2035 Global Market Insights Inc.
22-Jan-2026 United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors Businesswire
22-Jan-2026 Norovirus surge shows winter pressures continue to mount NHS Confederation
22-Jan-2026 Clinical Trials Market (Report) Transparency Market Research
22-Jan-2026 Diversatek Healthcare Announces the Launch of the EZ-Ject Injection Needle ACCESS Newswire
22-Jan-2026 Oxygen Therapy Equipment Market Analysis, Size, Share, Trends, Demand, Overview and Segment Forecast To 2029 Medi-Tech Insights
22-Jan-2026 Dawnzera™ (donidalorsen) granted European Union marketing authorisation for the prevention of hereditary angioedema Otsuka
22-Jan-2026 Home Healthcare Services Market Size, Share, Segmentation, Review, Trends, Opportunities, Growth, Demand and Forecast to 2029 Medi-Tech Insights
22-Jan-2026 Moolec Science S.A. Receives Nasdaq Panel Exception Through June 29, 2026 to Regain Compliance with Stockholders' Equity Requirement ACCESS Newswire
22-Jan-2026 Resolve M Therapeutics exits from stealth Resolve M Therapeutics
22-Jan-2026 Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi ACCESS Newswire
22-Jan-2026 IGC Pharma Expands Phase 2 CALMA Trial with New Clinical Trial Site at Integrative Clinical Trials in New York ACCESS Newswire
22-Jan-2026 Bioprocess Containers Market Analysis, Size, Share, Trends, Demand, Overview and Segment Forecast To 2029 Medi-Tech Insights
22-Jan-2026 Cell-Based Assays Market Size, Share, Demand, Growth, Demand by Forecast to 2029 Medi-Tech Insights
22-Jan-2026 Dosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA) PulseSight Therapeutics
22-Jan-2026 Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity ACCESS Newswire
22-Jan-2026 vVARDIS Advances Sustainable, Drill-Free Caries Management Consistent With WHO's Forward-Looking Vision for Environmentally Friendly Oral Health ACCESS Newswire
22-Jan-2026 Zomedica Enters Contract Manufacturing and Services Agreement with Rahm Sensor Development to Expand Revenue Streams Beyond Animal Health ACCESS Newswire
22-Jan-2026 Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target ACCESS Newswire